nodes	percent_of_prediction	percent_of_DWPC	metapath
Remifentanil—Musculoskeletal chest pain—Doxorubicin—thyroid cancer	0.00824	0.00824	CcSEcCtD
Remifentanil—Dysuria—Vandetanib—thyroid cancer	0.00812	0.00812	CcSEcCtD
Remifentanil—Pericarditis—Epirubicin—thyroid cancer	0.00798	0.00798	CcSEcCtD
Remifentanil—Haematochezia—Doxorubicin—thyroid cancer	0.00793	0.00793	CcSEcCtD
Remifentanil—Hyperglycaemia—Vandetanib—thyroid cancer	0.00783	0.00783	CcSEcCtD
Remifentanil—Pneumonia—Vandetanib—thyroid cancer	0.00779	0.00779	CcSEcCtD
Remifentanil—Hepatic function abnormal—Sorafenib—thyroid cancer	0.00776	0.00776	CcSEcCtD
Remifentanil—Renal failure—Vandetanib—thyroid cancer	0.00761	0.00761	CcSEcCtD
Remifentanil—Haematuria—Vandetanib—thyroid cancer	0.00738	0.00738	CcSEcCtD
Remifentanil—Pericarditis—Doxorubicin—thyroid cancer	0.00738	0.00738	CcSEcCtD
Remifentanil—Bradycardia—Vandetanib—thyroid cancer	0.00708	0.00708	CcSEcCtD
Remifentanil—Haemoglobin—Vandetanib—thyroid cancer	0.00699	0.00699	CcSEcCtD
Remifentanil—Haemorrhage—Vandetanib—thyroid cancer	0.00695	0.00695	CcSEcCtD
Remifentanil—Pneumothorax—Epirubicin—thyroid cancer	0.00694	0.00694	CcSEcCtD
Remifentanil—Lymphopenia—Epirubicin—thyroid cancer	0.00674	0.00674	CcSEcCtD
Remifentanil—Visual impairment—Vandetanib—thyroid cancer	0.0067	0.0067	CcSEcCtD
Remifentanil—Cardiac disorder—Vandetanib—thyroid cancer	0.00645	0.00645	CcSEcCtD
Remifentanil—Pneumothorax—Doxorubicin—thyroid cancer	0.00642	0.00642	CcSEcCtD
Remifentanil—Angiopathy—Vandetanib—thyroid cancer	0.00631	0.00631	CcSEcCtD
Remifentanil—Mediastinal disorder—Vandetanib—thyroid cancer	0.00627	0.00627	CcSEcCtD
Remifentanil—Lymphopenia—Doxorubicin—thyroid cancer	0.00624	0.00624	CcSEcCtD
Remifentanil—Arrhythmia—Vandetanib—thyroid cancer	0.00621	0.00621	CcSEcCtD
Remifentanil—Hypokalaemia—Sorafenib—thyroid cancer	0.00617	0.00617	CcSEcCtD
Remifentanil—Body temperature decreased—Epirubicin—thyroid cancer	0.00616	0.00616	CcSEcCtD
Remifentanil—Hypothermia—Epirubicin—thyroid cancer	0.00616	0.00616	CcSEcCtD
Remifentanil—Nasopharyngitis—Sorafenib—thyroid cancer	0.00606	0.00606	CcSEcCtD
Remifentanil—Dysphagia—Sorafenib—thyroid cancer	0.00586	0.00586	CcSEcCtD
Remifentanil—Hypothermia—Doxorubicin—thyroid cancer	0.0057	0.0057	CcSEcCtD
Remifentanil—Body temperature decreased—Doxorubicin—thyroid cancer	0.0057	0.0057	CcSEcCtD
Remifentanil—Tremor—Vandetanib—thyroid cancer	0.00567	0.00567	CcSEcCtD
Remifentanil—Abdominal discomfort—Sorafenib—thyroid cancer	0.00562	0.00562	CcSEcCtD
Remifentanil—Loss of consciousness—Vandetanib—thyroid cancer	0.00532	0.00532	CcSEcCtD
Remifentanil—Cough—Vandetanib—thyroid cancer	0.00528	0.00528	CcSEcCtD
Remifentanil—Pneumonia—Sorafenib—thyroid cancer	0.00525	0.00525	CcSEcCtD
Remifentanil—Convulsion—Vandetanib—thyroid cancer	0.00524	0.00524	CcSEcCtD
Remifentanil—Hypertension—Vandetanib—thyroid cancer	0.00522	0.00522	CcSEcCtD
Remifentanil—Renal failure—Sorafenib—thyroid cancer	0.00514	0.00514	CcSEcCtD
Remifentanil—Anxiety—Vandetanib—thyroid cancer	0.00513	0.00513	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.00512	0.00512	CcSEcCtD
Remifentanil—Dry mouth—Vandetanib—thyroid cancer	0.00504	0.00504	CcSEcCtD
Remifentanil—Oedema—Vandetanib—thyroid cancer	0.00494	0.00494	CcSEcCtD
Remifentanil—Ileus—Epirubicin—thyroid cancer	0.00488	0.00488	CcSEcCtD
Remifentanil—Nervous system disorder—Vandetanib—thyroid cancer	0.00484	0.00484	CcSEcCtD
Remifentanil—Thrombocytopenia—Vandetanib—thyroid cancer	0.00484	0.00484	CcSEcCtD
Remifentanil—Nystagmus—Epirubicin—thyroid cancer	0.00483	0.00483	CcSEcCtD
Remifentanil—Skin disorder—Vandetanib—thyroid cancer	0.0048	0.0048	CcSEcCtD
Remifentanil—Haemoglobin—Sorafenib—thyroid cancer	0.00471	0.00471	CcSEcCtD
Remifentanil—Haemorrhage—Sorafenib—thyroid cancer	0.00469	0.00469	CcSEcCtD
Remifentanil—Haemoptysis—Epirubicin—thyroid cancer	0.00466	0.00466	CcSEcCtD
Remifentanil—Ventricular arrhythmia—Epirubicin—thyroid cancer	0.00466	0.00466	CcSEcCtD
Remifentanil—Ileus—Doxorubicin—thyroid cancer	0.00451	0.00451	CcSEcCtD
Remifentanil—Pleural effusion—Epirubicin—thyroid cancer	0.00451	0.00451	CcSEcCtD
Remifentanil—Nystagmus—Doxorubicin—thyroid cancer	0.00447	0.00447	CcSEcCtD
Remifentanil—Paraesthesia—Vandetanib—thyroid cancer	0.00443	0.00443	CcSEcCtD
Remifentanil—Dyspnoea—Vandetanib—thyroid cancer	0.0044	0.0044	CcSEcCtD
Remifentanil—Cardiac disorder—Sorafenib—thyroid cancer	0.00435	0.00435	CcSEcCtD
Remifentanil—Flushing—Sorafenib—thyroid cancer	0.00435	0.00435	CcSEcCtD
Remifentanil—Dyspepsia—Vandetanib—thyroid cancer	0.00435	0.00435	CcSEcCtD
Remifentanil—Haemoptysis—Doxorubicin—thyroid cancer	0.00431	0.00431	CcSEcCtD
Remifentanil—Ventricular arrhythmia—Doxorubicin—thyroid cancer	0.00431	0.00431	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00426	0.00426	CcSEcCtD
Remifentanil—Angiopathy—Sorafenib—thyroid cancer	0.00425	0.00425	CcSEcCtD
Remifentanil—Immune system disorder—Sorafenib—thyroid cancer	0.00424	0.00424	CcSEcCtD
Remifentanil—Mediastinal disorder—Sorafenib—thyroid cancer	0.00423	0.00423	CcSEcCtD
Remifentanil—Constipation—Vandetanib—thyroid cancer	0.00422	0.00422	CcSEcCtD
Remifentanil—Pain—Vandetanib—thyroid cancer	0.00422	0.00422	CcSEcCtD
Remifentanil—Arrhythmia—Sorafenib—thyroid cancer	0.00419	0.00419	CcSEcCtD
Remifentanil—Pleural effusion—Doxorubicin—thyroid cancer	0.00417	0.00417	CcSEcCtD
Remifentanil—Erythema—Sorafenib—thyroid cancer	0.00408	0.00408	CcSEcCtD
Remifentanil—Body temperature increased—Vandetanib—thyroid cancer	0.0039	0.0039	CcSEcCtD
Remifentanil—Ventricular extrasystoles—Epirubicin—thyroid cancer	0.00382	0.00382	CcSEcCtD
Remifentanil—Anaemia—Sorafenib—thyroid cancer	0.00377	0.00377	CcSEcCtD
Remifentanil—Oliguria—Epirubicin—thyroid cancer	0.00374	0.00374	CcSEcCtD
Remifentanil—Dyskinesia—Epirubicin—thyroid cancer	0.00367	0.00367	CcSEcCtD
Remifentanil—Syncope—Sorafenib—thyroid cancer	0.00366	0.00366	CcSEcCtD
Remifentanil—Loss of consciousness—Sorafenib—thyroid cancer	0.00359	0.00359	CcSEcCtD
Remifentanil—Cough—Sorafenib—thyroid cancer	0.00356	0.00356	CcSEcCtD
Remifentanil—Atrioventricular block—Epirubicin—thyroid cancer	0.00356	0.00356	CcSEcCtD
Remifentanil—Ventricular extrasystoles—Doxorubicin—thyroid cancer	0.00354	0.00354	CcSEcCtD
Remifentanil—Hypertension—Sorafenib—thyroid cancer	0.00352	0.00352	CcSEcCtD
Remifentanil—Pruritus—Vandetanib—thyroid cancer	0.00349	0.00349	CcSEcCtD
Remifentanil—Oliguria—Doxorubicin—thyroid cancer	0.00347	0.00347	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00345	0.00345	CcSEcCtD
Remifentanil—Hiccups—Epirubicin—thyroid cancer	0.00345	0.00345	CcSEcCtD
Remifentanil—Dry mouth—Sorafenib—thyroid cancer	0.0034	0.0034	CcSEcCtD
Remifentanil—Dyskinesia—Doxorubicin—thyroid cancer	0.0034	0.0034	CcSEcCtD
Remifentanil—Hyperkalaemia—Epirubicin—thyroid cancer	0.00339	0.00339	CcSEcCtD
Remifentanil—Diarrhoea—Vandetanib—thyroid cancer	0.00338	0.00338	CcSEcCtD
Remifentanil—Anaphylactic shock—Sorafenib—thyroid cancer	0.00333	0.00333	CcSEcCtD
Remifentanil—Atrioventricular block—Doxorubicin—thyroid cancer	0.00329	0.00329	CcSEcCtD
Remifentanil—Shock—Sorafenib—thyroid cancer	0.00328	0.00328	CcSEcCtD
Remifentanil—Nervous system disorder—Sorafenib—thyroid cancer	0.00327	0.00327	CcSEcCtD
Remifentanil—Dizziness—Vandetanib—thyroid cancer	0.00327	0.00327	CcSEcCtD
Remifentanil—Thrombocytopenia—Sorafenib—thyroid cancer	0.00326	0.00326	CcSEcCtD
Remifentanil—Skin disorder—Sorafenib—thyroid cancer	0.00324	0.00324	CcSEcCtD
Remifentanil—Hiccups—Doxorubicin—thyroid cancer	0.00319	0.00319	CcSEcCtD
Remifentanil—Vomiting—Vandetanib—thyroid cancer	0.00314	0.00314	CcSEcCtD
Remifentanil—Hyperkalaemia—Doxorubicin—thyroid cancer	0.00314	0.00314	CcSEcCtD
Remifentanil—Rash—Vandetanib—thyroid cancer	0.00311	0.00311	CcSEcCtD
Remifentanil—Dermatitis—Vandetanib—thyroid cancer	0.00311	0.00311	CcSEcCtD
Remifentanil—Headache—Vandetanib—thyroid cancer	0.00309	0.00309	CcSEcCtD
Remifentanil—Pulmonary oedema—Epirubicin—thyroid cancer	0.00307	0.00307	CcSEcCtD
Remifentanil—Dyspnoea—Sorafenib—thyroid cancer	0.00297	0.00297	CcSEcCtD
Remifentanil—Nausea—Vandetanib—thyroid cancer	0.00293	0.00293	CcSEcCtD
Remifentanil—Dyspepsia—Sorafenib—thyroid cancer	0.00293	0.00293	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00288	0.00288	CcSEcCtD
Remifentanil—Hepatic function abnormal—Epirubicin—thyroid cancer	0.00287	0.00287	CcSEcCtD
Remifentanil—Pain—Sorafenib—thyroid cancer	0.00285	0.00285	CcSEcCtD
Remifentanil—Constipation—Sorafenib—thyroid cancer	0.00285	0.00285	CcSEcCtD
Remifentanil—Pulmonary oedema—Doxorubicin—thyroid cancer	0.00284	0.00284	CcSEcCtD
Remifentanil—Hepatic function abnormal—Doxorubicin—thyroid cancer	0.00265	0.00265	CcSEcCtD
Remifentanil—Urticaria—Sorafenib—thyroid cancer	0.00265	0.00265	CcSEcCtD
Remifentanil—Body temperature increased—Sorafenib—thyroid cancer	0.00263	0.00263	CcSEcCtD
Remifentanil—Renal impairment—Epirubicin—thyroid cancer	0.00263	0.00263	CcSEcCtD
Remifentanil—Hypersensitivity—Sorafenib—thyroid cancer	0.00245	0.00245	CcSEcCtD
Remifentanil—Renal impairment—Doxorubicin—thyroid cancer	0.00244	0.00244	CcSEcCtD
Remifentanil—Cardiac arrest—Epirubicin—thyroid cancer	0.00238	0.00238	CcSEcCtD
Remifentanil—Pruritus—Sorafenib—thyroid cancer	0.00236	0.00236	CcSEcCtD
Remifentanil—Hypokalaemia—Epirubicin—thyroid cancer	0.00228	0.00228	CcSEcCtD
Remifentanil—Diarrhoea—Sorafenib—thyroid cancer	0.00228	0.00228	CcSEcCtD
Remifentanil—Nasopharyngitis—Epirubicin—thyroid cancer	0.00224	0.00224	CcSEcCtD
Remifentanil—Cardiac arrest—Doxorubicin—thyroid cancer	0.0022	0.0022	CcSEcCtD
Remifentanil—Dizziness—Sorafenib—thyroid cancer	0.0022	0.0022	CcSEcCtD
Remifentanil—Dysphagia—Epirubicin—thyroid cancer	0.00217	0.00217	CcSEcCtD
Remifentanil—Vomiting—Sorafenib—thyroid cancer	0.00212	0.00212	CcSEcCtD
Remifentanil—Hypokalaemia—Doxorubicin—thyroid cancer	0.00211	0.00211	CcSEcCtD
Remifentanil—Rash—Sorafenib—thyroid cancer	0.0021	0.0021	CcSEcCtD
Remifentanil—Dermatitis—Sorafenib—thyroid cancer	0.0021	0.0021	CcSEcCtD
Remifentanil—Headache—Sorafenib—thyroid cancer	0.00209	0.00209	CcSEcCtD
Remifentanil—Bronchitis—Epirubicin—thyroid cancer	0.00208	0.00208	CcSEcCtD
Remifentanil—Nasopharyngitis—Doxorubicin—thyroid cancer	0.00207	0.00207	CcSEcCtD
Remifentanil—Dysuria—Epirubicin—thyroid cancer	0.00202	0.00202	CcSEcCtD
Remifentanil—Dysphagia—Doxorubicin—thyroid cancer	0.002	0.002	CcSEcCtD
Remifentanil—Nausea—Sorafenib—thyroid cancer	0.00198	0.00198	CcSEcCtD
Remifentanil—Hyperglycaemia—Epirubicin—thyroid cancer	0.00195	0.00195	CcSEcCtD
Remifentanil—Pneumonia—Epirubicin—thyroid cancer	0.00194	0.00194	CcSEcCtD
Remifentanil—Bronchitis—Doxorubicin—thyroid cancer	0.00193	0.00193	CcSEcCtD
Remifentanil—Renal failure—Epirubicin—thyroid cancer	0.0019	0.0019	CcSEcCtD
Remifentanil—Dysuria—Doxorubicin—thyroid cancer	0.00187	0.00187	CcSEcCtD
Remifentanil—Sweating—Epirubicin—thyroid cancer	0.00185	0.00185	CcSEcCtD
Remifentanil—Haematuria—Epirubicin—thyroid cancer	0.00184	0.00184	CcSEcCtD
Remifentanil—Hyperglycaemia—Doxorubicin—thyroid cancer	0.00181	0.00181	CcSEcCtD
Remifentanil—Pneumonia—Doxorubicin—thyroid cancer	0.0018	0.0018	CcSEcCtD
Remifentanil—Bradycardia—Epirubicin—thyroid cancer	0.00176	0.00176	CcSEcCtD
Remifentanil—Renal failure—Doxorubicin—thyroid cancer	0.00176	0.00176	CcSEcCtD
Remifentanil—Haemoglobin—Epirubicin—thyroid cancer	0.00174	0.00174	CcSEcCtD
Remifentanil—Haemorrhage—Epirubicin—thyroid cancer	0.00173	0.00173	CcSEcCtD
Remifentanil—Pharyngitis—Epirubicin—thyroid cancer	0.00172	0.00172	CcSEcCtD
Remifentanil—Sweating—Doxorubicin—thyroid cancer	0.00171	0.00171	CcSEcCtD
Remifentanil—Haematuria—Doxorubicin—thyroid cancer	0.0017	0.0017	CcSEcCtD
Remifentanil—Visual impairment—Epirubicin—thyroid cancer	0.00167	0.00167	CcSEcCtD
Remifentanil—Bradycardia—Doxorubicin—thyroid cancer	0.00163	0.00163	CcSEcCtD
Remifentanil—Haemoglobin—Doxorubicin—thyroid cancer	0.00161	0.00161	CcSEcCtD
Remifentanil—Flushing—Epirubicin—thyroid cancer	0.00161	0.00161	CcSEcCtD
Remifentanil—Cardiac disorder—Epirubicin—thyroid cancer	0.00161	0.00161	CcSEcCtD
Remifentanil—Haemorrhage—Doxorubicin—thyroid cancer	0.0016	0.0016	CcSEcCtD
Remifentanil—Pharyngitis—Doxorubicin—thyroid cancer	0.00159	0.00159	CcSEcCtD
Remifentanil—Angiopathy—Epirubicin—thyroid cancer	0.00157	0.00157	CcSEcCtD
Remifentanil—Immune system disorder—Epirubicin—thyroid cancer	0.00157	0.00157	CcSEcCtD
Remifentanil—Mediastinal disorder—Epirubicin—thyroid cancer	0.00156	0.00156	CcSEcCtD
Remifentanil—Chills—Epirubicin—thyroid cancer	0.00156	0.00156	CcSEcCtD
Remifentanil—Arrhythmia—Epirubicin—thyroid cancer	0.00155	0.00155	CcSEcCtD
Remifentanil—Visual impairment—Doxorubicin—thyroid cancer	0.00155	0.00155	CcSEcCtD
Remifentanil—Erythema—Epirubicin—thyroid cancer	0.00151	0.00151	CcSEcCtD
Remifentanil—Flushing—Doxorubicin—thyroid cancer	0.00149	0.00149	CcSEcCtD
Remifentanil—Cardiac disorder—Doxorubicin—thyroid cancer	0.00149	0.00149	CcSEcCtD
Remifentanil—Angiopathy—Doxorubicin—thyroid cancer	0.00145	0.00145	CcSEcCtD
Remifentanil—Immune system disorder—Doxorubicin—thyroid cancer	0.00145	0.00145	CcSEcCtD
Remifentanil—Mediastinal disorder—Doxorubicin—thyroid cancer	0.00145	0.00145	CcSEcCtD
Remifentanil—Chills—Doxorubicin—thyroid cancer	0.00144	0.00144	CcSEcCtD
Remifentanil—Arrhythmia—Doxorubicin—thyroid cancer	0.00143	0.00143	CcSEcCtD
Remifentanil—Erythema—Doxorubicin—thyroid cancer	0.0014	0.0014	CcSEcCtD
Remifentanil—Anaemia—Epirubicin—thyroid cancer	0.00139	0.00139	CcSEcCtD
Remifentanil—Agitation—Epirubicin—thyroid cancer	0.00139	0.00139	CcSEcCtD
Remifentanil—Syncope—Epirubicin—thyroid cancer	0.00135	0.00135	CcSEcCtD
Remifentanil—Loss of consciousness—Epirubicin—thyroid cancer	0.00133	0.00133	CcSEcCtD
Remifentanil—Cough—Epirubicin—thyroid cancer	0.00132	0.00132	CcSEcCtD
Remifentanil—Convulsion—Epirubicin—thyroid cancer	0.00131	0.00131	CcSEcCtD
Remifentanil—Hypertension—Epirubicin—thyroid cancer	0.0013	0.0013	CcSEcCtD
Remifentanil—Anaemia—Doxorubicin—thyroid cancer	0.00129	0.00129	CcSEcCtD
Remifentanil—Agitation—Doxorubicin—thyroid cancer	0.00128	0.00128	CcSEcCtD
Remifentanil—Anxiety—Epirubicin—thyroid cancer	0.00128	0.00128	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.00128	0.00128	CcSEcCtD
Remifentanil—Dry mouth—Epirubicin—thyroid cancer	0.00126	0.00126	CcSEcCtD
Remifentanil—Syncope—Doxorubicin—thyroid cancer	0.00125	0.00125	CcSEcCtD
Remifentanil—Confusional state—Epirubicin—thyroid cancer	0.00124	0.00124	CcSEcCtD
Remifentanil—Oedema—Epirubicin—thyroid cancer	0.00123	0.00123	CcSEcCtD
Remifentanil—Anaphylactic shock—Epirubicin—thyroid cancer	0.00123	0.00123	CcSEcCtD
Remifentanil—Loss of consciousness—Doxorubicin—thyroid cancer	0.00123	0.00123	CcSEcCtD
Remifentanil—Cough—Doxorubicin—thyroid cancer	0.00122	0.00122	CcSEcCtD
Remifentanil—Shock—Epirubicin—thyroid cancer	0.00121	0.00121	CcSEcCtD
Remifentanil—Convulsion—Doxorubicin—thyroid cancer	0.00121	0.00121	CcSEcCtD
Remifentanil—Nervous system disorder—Epirubicin—thyroid cancer	0.00121	0.00121	CcSEcCtD
Remifentanil—Thrombocytopenia—Epirubicin—thyroid cancer	0.00121	0.00121	CcSEcCtD
Remifentanil—Hypertension—Doxorubicin—thyroid cancer	0.00121	0.00121	CcSEcCtD
Remifentanil—Tachycardia—Epirubicin—thyroid cancer	0.0012	0.0012	CcSEcCtD
Remifentanil—Skin disorder—Epirubicin—thyroid cancer	0.0012	0.0012	CcSEcCtD
Remifentanil—Hyperhidrosis—Epirubicin—thyroid cancer	0.00119	0.00119	CcSEcCtD
Remifentanil—Anxiety—Doxorubicin—thyroid cancer	0.00118	0.00118	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.00118	0.00118	CcSEcCtD
Remifentanil—Dry mouth—Doxorubicin—thyroid cancer	0.00116	0.00116	CcSEcCtD
Remifentanil—Hypotension—Epirubicin—thyroid cancer	0.00115	0.00115	CcSEcCtD
Remifentanil—Confusional state—Doxorubicin—thyroid cancer	0.00115	0.00115	CcSEcCtD
Remifentanil—Oedema—Doxorubicin—thyroid cancer	0.00114	0.00114	CcSEcCtD
Remifentanil—Anaphylactic shock—Doxorubicin—thyroid cancer	0.00114	0.00114	CcSEcCtD
Remifentanil—Shock—Doxorubicin—thyroid cancer	0.00112	0.00112	CcSEcCtD
Remifentanil—Nervous system disorder—Doxorubicin—thyroid cancer	0.00112	0.00112	CcSEcCtD
Remifentanil—Thrombocytopenia—Doxorubicin—thyroid cancer	0.00112	0.00112	CcSEcCtD
Remifentanil—Tachycardia—Doxorubicin—thyroid cancer	0.00111	0.00111	CcSEcCtD
Remifentanil—Skin disorder—Doxorubicin—thyroid cancer	0.00111	0.00111	CcSEcCtD
Remifentanil—Paraesthesia—Epirubicin—thyroid cancer	0.00111	0.00111	CcSEcCtD
Remifentanil—Hyperhidrosis—Doxorubicin—thyroid cancer	0.0011	0.0011	CcSEcCtD
Remifentanil—Dyspnoea—Epirubicin—thyroid cancer	0.0011	0.0011	CcSEcCtD
Remifentanil—Somnolence—Epirubicin—thyroid cancer	0.00109	0.00109	CcSEcCtD
Remifentanil—Dyspepsia—Epirubicin—thyroid cancer	0.00108	0.00108	CcSEcCtD
Remifentanil—Hypotension—Doxorubicin—thyroid cancer	0.00106	0.00106	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.00106	0.00106	CcSEcCtD
Remifentanil—Pain—Epirubicin—thyroid cancer	0.00105	0.00105	CcSEcCtD
Remifentanil—Constipation—Epirubicin—thyroid cancer	0.00105	0.00105	CcSEcCtD
Remifentanil—Paraesthesia—Doxorubicin—thyroid cancer	0.00102	0.00102	CcSEcCtD
Remifentanil—Dyspnoea—Doxorubicin—thyroid cancer	0.00102	0.00102	CcSEcCtD
Remifentanil—Feeling abnormal—Epirubicin—thyroid cancer	0.00101	0.00101	CcSEcCtD
Remifentanil—Somnolence—Doxorubicin—thyroid cancer	0.00101	0.00101	CcSEcCtD
Remifentanil—Dyspepsia—Doxorubicin—thyroid cancer	0.001	0.001	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000984	0.000984	CcSEcCtD
Remifentanil—Urticaria—Epirubicin—thyroid cancer	0.000978	0.000978	CcSEcCtD
Remifentanil—Constipation—Doxorubicin—thyroid cancer	0.000974	0.000974	CcSEcCtD
Remifentanil—Pain—Doxorubicin—thyroid cancer	0.000974	0.000974	CcSEcCtD
Remifentanil—Body temperature increased—Epirubicin—thyroid cancer	0.000973	0.000973	CcSEcCtD
Remifentanil—Feeling abnormal—Doxorubicin—thyroid cancer	0.000939	0.000939	CcSEcCtD
Remifentanil—Hypersensitivity—Epirubicin—thyroid cancer	0.000907	0.000907	CcSEcCtD
Remifentanil—Urticaria—Doxorubicin—thyroid cancer	0.000905	0.000905	CcSEcCtD
Remifentanil—Body temperature increased—Doxorubicin—thyroid cancer	0.000901	0.000901	CcSEcCtD
Remifentanil—Pruritus—Epirubicin—thyroid cancer	0.000871	0.000871	CcSEcCtD
Remifentanil—Diarrhoea—Epirubicin—thyroid cancer	0.000842	0.000842	CcSEcCtD
Remifentanil—Hypersensitivity—Doxorubicin—thyroid cancer	0.000839	0.000839	CcSEcCtD
Remifentanil—Dizziness—Epirubicin—thyroid cancer	0.000814	0.000814	CcSEcCtD
Remifentanil—Pruritus—Doxorubicin—thyroid cancer	0.000806	0.000806	CcSEcCtD
Remifentanil—Vomiting—Epirubicin—thyroid cancer	0.000783	0.000783	CcSEcCtD
Remifentanil—Diarrhoea—Doxorubicin—thyroid cancer	0.00078	0.00078	CcSEcCtD
Remifentanil—Rash—Epirubicin—thyroid cancer	0.000776	0.000776	CcSEcCtD
Remifentanil—Dermatitis—Epirubicin—thyroid cancer	0.000776	0.000776	CcSEcCtD
Remifentanil—Headache—Epirubicin—thyroid cancer	0.000771	0.000771	CcSEcCtD
Remifentanil—Dizziness—Doxorubicin—thyroid cancer	0.000753	0.000753	CcSEcCtD
Remifentanil—Nausea—Epirubicin—thyroid cancer	0.000731	0.000731	CcSEcCtD
Remifentanil—Vomiting—Doxorubicin—thyroid cancer	0.000724	0.000724	CcSEcCtD
Remifentanil—Rash—Doxorubicin—thyroid cancer	0.000718	0.000718	CcSEcCtD
Remifentanil—Dermatitis—Doxorubicin—thyroid cancer	0.000718	0.000718	CcSEcCtD
Remifentanil—Headache—Doxorubicin—thyroid cancer	0.000714	0.000714	CcSEcCtD
Remifentanil—Nausea—Doxorubicin—thyroid cancer	0.000677	0.000677	CcSEcCtD
